NL7203042A - - Google Patents
Info
- Publication number
- NL7203042A NL7203042A NL7203042A NL7203042A NL7203042A NL 7203042 A NL7203042 A NL 7203042A NL 7203042 A NL7203042 A NL 7203042A NL 7203042 A NL7203042 A NL 7203042A NL 7203042 A NL7203042 A NL 7203042A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7203042A NL7203042A (en:Method) | 1972-03-08 | 1972-03-08 | |
| ZA731207A ZA731207B (en) | 1972-03-08 | 1973-02-20 | Psychopharmacologically active peptides |
| AU52511/73A AU471618B2 (en) | 1972-03-08 | 1973-02-22 | Psychopharma cologically active peptides |
| GB1006273A GB1425099A (en) | 1972-03-08 | 1973-03-01 | Psychopharmacologically active peptides |
| HUAO352A HU169157B (en:Method) | 1972-03-08 | 1973-03-05 | |
| CH328873A CH584681A5 (en:Method) | 1972-03-08 | 1973-03-06 | |
| DE19732311099 DE2311099A1 (de) | 1972-03-08 | 1973-03-06 | Psychopharmakologisch aktive peptide und peptidderivate |
| CA165,427A CA1025439A (en) | 1972-03-08 | 1973-03-07 | Psychopharmacologically active peptides |
| SE7303180A SE406761B (sv) | 1972-03-08 | 1973-03-07 | Sett att framstella peptider med psykofarmakologiska egenskaper |
| JP48026885A JPS48103575A (en:Method) | 1972-03-08 | 1973-03-07 | |
| FR7308346A FR2181803B1 (en:Method) | 1972-03-08 | 1973-03-08 | |
| BE128545A BE796478A (fr) | 1972-03-08 | 1973-03-08 | Nouveaux peptides et derives de peptides a action psychopharmacologique |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7203042A NL7203042A (en:Method) | 1972-03-08 | 1972-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7203042A true NL7203042A (en:Method) | 1973-09-11 |
Family
ID=19815540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7203042A NL7203042A (en:Method) | 1972-03-08 | 1972-03-08 |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS48103575A (en:Method) |
| AU (1) | AU471618B2 (en:Method) |
| BE (1) | BE796478A (en:Method) |
| CA (1) | CA1025439A (en:Method) |
| CH (1) | CH584681A5 (en:Method) |
| DE (1) | DE2311099A1 (en:Method) |
| FR (1) | FR2181803B1 (en:Method) |
| GB (1) | GB1425099A (en:Method) |
| HU (1) | HU169157B (en:Method) |
| NL (1) | NL7203042A (en:Method) |
| SE (1) | SE406761B (en:Method) |
| ZA (1) | ZA731207B (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4587233A (en) * | 1983-11-07 | 1986-05-06 | Board Of Trustees Of The Leland Stanford Junior University | Use of Arg-Phe-amide derivatives |
| WO2011133348A1 (en) | 2010-04-21 | 2011-10-27 | Pharmacofore, Inc. | Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof |
| WO2023055830A1 (en) | 2021-09-29 | 2023-04-06 | Ensysce Biosciences, Inc. | Enzyme-cleavable methadone prodrugs and methods of use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1301738A (en:Method) * | 1969-07-09 | 1973-01-04 |
-
1972
- 1972-03-08 NL NL7203042A patent/NL7203042A/xx not_active Application Discontinuation
-
1973
- 1973-02-20 ZA ZA731207A patent/ZA731207B/xx unknown
- 1973-02-22 AU AU52511/73A patent/AU471618B2/en not_active Expired
- 1973-03-01 GB GB1006273A patent/GB1425099A/en not_active Expired
- 1973-03-05 HU HUAO352A patent/HU169157B/hu unknown
- 1973-03-06 CH CH328873A patent/CH584681A5/xx not_active IP Right Cessation
- 1973-03-06 DE DE19732311099 patent/DE2311099A1/de active Pending
- 1973-03-07 SE SE7303180A patent/SE406761B/xx unknown
- 1973-03-07 JP JP48026885A patent/JPS48103575A/ja active Pending
- 1973-03-07 CA CA165,427A patent/CA1025439A/en not_active Expired
- 1973-03-08 FR FR7308346A patent/FR2181803B1/fr not_active Expired
- 1973-03-08 BE BE128545A patent/BE796478A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1425099A (en) | 1976-02-18 |
| HU169157B (en:Method) | 1976-10-28 |
| FR2181803B1 (en:Method) | 1976-09-03 |
| DE2311099A1 (de) | 1973-09-13 |
| FR2181803A1 (en:Method) | 1973-12-07 |
| AU471618B2 (en) | 1976-04-29 |
| CH584681A5 (en:Method) | 1977-02-15 |
| CA1025439A (en) | 1978-01-31 |
| SE406761B (sv) | 1979-02-26 |
| ZA731207B (en) | 1973-11-28 |
| AU5251173A (en) | 1974-08-22 |
| JPS48103575A (en:Method) | 1973-12-25 |
| BE796478A (fr) | 1973-09-10 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BV | The patent application has lapsed |